World-Leading Regulatory Affairs Expert Joins Inceptua Group
World-Leading Regulatory Affairs Expert Joins Inceptua Group Luxembourg,...
Read More
Inceptua receives approval of marketing authorization transfer of Apealea® (paclitaxel micellar) for the treatment of ovarian cancer
European Commission and MHRA approves transfer of marketing...
Read More
When is an Early Access Program not the right option?
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Scott Forde joins Inceptua as Senior Director, Business Development.
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Inceptua strengthens early access division with key business development hire
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
When Early Access Programs Go Bad
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Oasmia announces transfer of Nordic commercialization rights for Apealea® (Paclitaxel Micellar) to Inceptua
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Is there a role for Ethics Committees in Early Access?
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Elevar Therapeutics Inc. Announces Licensing Agreement with Inceptua Group
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Inceptua Partners with Global Blood Therapeutics for an Early Access Program for Voxelotor for Patients with Sickle Cell Disease
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Webinar: Strategic Comparator Sourcing in China
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Safely and Reliably Supplying your Comparator Needs during COVID19
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Helping get orphan drugs to patients quicker
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Inceptua receives approval of marketing authorization transfer of Jetrea® (ocriplasmin) for the treatment of symptomatic vitreomacular adhesion
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Inceptua Group Announces Partnership with BioCryst on Expanded Access Program for Patients with Hereditary Angioedema
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More
Global License Agreement a Building Block in Strategic Growth Plans
Lorem ipsum dolor sit amet, consectetur adipiscing elit....
Read More